Physician profile
Jason Liu
NPI 1770945909
$24,931.63
in general payments reported to CMS, 2019-2025
46 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $873 · 2020: $1,465 · 2021: $1,572 · 2022: $1,761 · 2023: $2,908 · 2024: $3,815 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $5,580 · Travel and Lodging: $1,764 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,835.57 |
| Consulting Fee | $5,580.00 |
| Travel and Lodging | $1,764.37 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $4,194.83 | 2024-2025 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $4,173.20 | 2021-2025 | |
| Biotronik INC. | $2,743.54 | 2022-2025 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Actelion Pharmaceuticals US, INC. | $2,068.26 | 2020-2025 | Opsumit, Uptravi, Opsynvi |
| Abbott Laboratories | $1,688.46 | 2025 | Amplatzer Amulet, Triclip, Dragonfly Opstar |
| Novo Nordisk INC | $1,306.25 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,286.24 | 2020-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,032.10 | 2020-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $912.62 | 2019-2025 | Wainua, Farxiga |
| Amgen INC. | $669.30 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $563.41 | 2019-2025 | Watchman Flx, Farapulse, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $414.23 | 2019-2025 | |
| Astellas Pharma US INC | $328.06 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $312.01 | 2020-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $306.61 | 2020-2025 | Camzyos, Eliquis |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $283.39 | 2022-2025 | Atriclip Laa Exclusion System |
| Merck Sharp & Dohme LLC | $260.79 | 2022-2025 | Verquvo |
| Chiesi USA, INC. | $230.11 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $190.37 | 2019 | |
| Medtronic Vascular, INC. | $171.49 | 2019 | |
| Impulse Dynamics (USA) INC. | $168.02 | 2022 | |
| Medtronic, INC. | $162.23 | 2021 | |
| Surmodics, INC. | $133.79 | 2023 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Esperion Therapeutics, INC. | $128.50 | 2021-2025 | Nexletol |
| Lundbeck LLC | $113.36 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $111.44 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $107.54 | 2024-2025 | |
| Edwards Lifesciences Corporation | $102.74 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Irhythm Technologies, INC. | $100.74 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Cathworks, INC. | $98.73 | 2020 | |
| Sanofi-Aventis U.S. LLC | $94.77 | 2019-2024 | |
| Kestra Medical Technology Services, INC. | $65.58 | 2024 | Assure Wcd |
| Heartflow, INC. | $53.76 | 2022-2025 | Ffrct |
| Baxter Healthcare | $47.44 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $46.16 | 2024 | Arcalyst |
| Biohaven Pharmaceutical Holding Company LTD. | $41.58 | 2022 | |
| Bridgebio Pharma, INC. | $31.95 | 2025 | Attruby |
| Philips North America LLC | $25.90 | 2024 | (5050) Ext Holter |
| Shockwave Medical, INC | $25.58 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cleerly, INC. | $25.10 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Daiichi Sankyo INC. | $24.30 | 2023 | Injectafer |
| Kiniksa Pharmaceuticals, LTD. | $22.26 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $18.30 | 2024 | |
| Getinge USA Sales, LLC | $17.24 | 2020 | |
| Biosense Webster, INC. | $15.22 | 2020 | |
| Abiomed | $14.13 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.